Effect of Low dose platelet transfusion in adult cancer patients.
Not Applicable
Completed
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2022/11/047715
- Lead Sponsor
- RELIABLE CORPORATIO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1) Patient with age >18 years.
2) Patients fulfilling the institutional guidelines for prophylactic platelet transfusion.
Exclusion Criteria
1)Patients on drugs known to cause thrombocytopenia or platelet dysfunction eg. Vancomycin,
Amphotericin B, Aspirin.
2) Patientâ??s having immune and non-immune causes of platelet refractoriness like fever, sepsis,
bleeding, DIC, splenomegaly.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method